glp-1 treatment gonzales GLP Weight Loss Medications Schematic illustration of monoagonists, dual

Clinical Trial Results STEP trials (Semaglutide Treatment Effect in People with obesity): Average weight loss of ~15% of total body weight

While most GLP-1-related headaches are mild and self-limiting, certain presentations require prompt medical evaluation

7 Safety considerations and patient selection GLP-1 receptor agonists have a well-defined safety profile

Therefore, it is essential to be cautious about the use of Ozempic as a weight loss drug until more research is conducted to better understand its long-term impact on health

Zepbound is appropriate for adults with obesity or those with related health conditions like high blood pressure or diabetes